Market Place
Sourcing Support
All News #Library
Rare Diseases
Intrabio Gets Ema`s Positive Opinion For Acetylleucine
24 Feb 2026 //
BUSINESSWIRE
Intrabio Details Positive Levacetylleucine Trial
11 Feb 2026 //
BUSINESSWIRE
EU Approves AQNEURSA for Niemann-Pick Type C
28 Jan 2026 //
INDPHARMAPOST
Intrabio Gets EU Approval for Aqneursa in Niemann-Pick Type C
22 Jan 2026 //
BUSINESSWIRE
Intrabio Reports Successful Levacetylleucine Trial
22 Jan 2026 //
BUSINESSWIRE
CHMP Recommends AQNEURSA For Niemann-Pick Approval In EU
29 Jul 2025 //
BUSINESSWIRE
IntraBio hits the ground running with new rare disease launch
30 Sep 2024 //
FIERCE PHARMA
Curant Selected As Exclusive Specialty Pharmacy For AQNEURSA
30 Sep 2024 //
BUSINESSWIRE
US FDA approves IntraBio`s drug for rare genetic disease
25 Sep 2024 //
REUTERS
Copyright © 2026 LePro PharmaCompass OPC Private Limited, All rights reserved.